home . news & publications . Investment News . Azerbaijan in Talks with Foreign Companies on Joint Drug Output

Azerbaijan in Talks with Foreign Companies on Joint Drug Output

Azerbaijan is conducting negotiations with companies from Turkey, Ukraine, Germany and Switzerland for joint output of pharmaceutical products, Azerbaijan's Economy Ministry said in a message.

The country also has agreements with two foreign companies – Iran's Tamin Pharmaceutical Investment Company and Russia's R-Pharm.

Tamin Pharmaceutical Investment Company is Iran's largest pharmaceutical holding combining 31 companies. The company signed a memorandum of understanding with Azerbaijan's Azersun Holding that envisages the production of medicines in Azerbaijan's Sumgait Chemical Industrial Park.

Based on this project, medicine production will be implemented in several phases. During the first phase, the joint venture will produce 84 kinds of various vitamins, antihistamines, diabetic and anti-infective drugs as well as medicines for diseases of nervous system and gastroenterological diseases.

Meanwhile, Azerbaijan Investment Company and Vita-A company signed a protocol of intention with Russia's R-Pharm company in June to produce medicines. Hayat Pharm company was established with this purpose. The joint venture, cost of which is estimated at 47 million manats, will produce antibiotics and drugs for cancer, neurological, psychiatric diseases, hepatitis and AIDS. The project is expected to create 200 new jobs. The drugs will be exported to Georgia, Iran, Turkey, Central Asia and Ukraine.

Source: Trend 

Back to top


events view our upcoming events.

network follow us.

   facebook  linkedin  twitter

anglo-asian ata-holding
azpetrol statoil
bny_melon azertrans
chevron_logo conocophillips
  ibar exxonmobil
 solar-turbines boeing-logo-website